Close Menu

Co-morbidities, Metabolic and Malignancy Risk Profile in Patients with Psoriasis

DOI: 
10.7727/wimj.2015.454

INTRODUCTION

Psoriasis is a hereditary skin disorder of unknown etiology which affects to 1-3% of the general population worldwide. The most common physical symptom of psoriasis is the presence of thick, dry, red skin lesions in form of plaques covered by silvery scales. The extent of body surface areas affected by this condition is variable, ranging from limited disease (< 2% body surface affected) in nearly 80 % of patients to more extensive skin involvement in 20 % of patients. As a chronic inflammatory cutaneous disease, psoriasis is associated with impairments which affect to the quality of life of patients even in limited or mild cases. Despite of improvements in therapies with biologic agents, there are emerging comorbidities associated with this cutaneous condition as patients with psoriasis show higher incidence of comorbidities than expected (1-6). Such comorbidities include: obesity, diabetes, cardiovascular disease, different types of cancer, depression, inflammatory bowel disease and psoriatic arthritis. Although the relationship between psoriasis and most of comorbidities is not completely clear, it is likely to be linked to the inflammatory nature of psoriasis. However, epidemiological studies suggest the role of the psoriasis as an independent risk factor of these outcomes. Advances in the knowledge of the pathogenesis of psoriasis and these comorbidities have discovered common physiopathologic mechanisms which may provide a biological plausibility of the associations and explain why such disorders are more frequently observed in these patients through epidemiological studies. 

Accepted: 
25 Nov, 2015
PDF Attachment: 
e-Published: 30 Mar, 2016

Disclaimer

Manuscripts that are Published Ahead of Print have been peer reviewed and accepted for publication by the Editorial Board of the West Indian Medical Journal. They may appear in their original format and may not be copy edited or formatted in the style guide of this Journal. While accepted manuscripts are not yet assigned a volume, issue or page numbers, they can be cited using the DOI and date of e-publication. See our Instructions for Authors on how to properly cite manuscripts at this stage. The contents of the manuscript may change before it is published in its final form. Manuscripts in this section will be removed once they have been issued to a volume and issue, but will still retain the DOI and date of e-publication.

Top of Page